Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

November 12, 2022

Study Completion Date

December 1, 2022

Conditions
Pediatric Cancer
Interventions
DRUG

Bupivacaine Hydrochloride

The patient will be placed in a sitting position under complete aseptic condition and a cover sheath will be used for the ultrasound probe with an appropriate amount of lubricating gel applied on the probe, a high-frequency linear ultrasound transducer will be placed in a longitudinal orientation 3 cm lateral to the L3 spinous process. This should reveal three muscles superficial to the hyperechoic transverse process shadow as follows: trapezius, rhomboid major, and erector spinae. then injecte bupivacaine hydrochloride

DRUG

Tramadol hydrochloride

Patients in group Tramadol will intravenously administrate dose of 1 mg/kg/8hr tramal to be increased upon patient needs up to 2mg/kg/6hr as rescue analgesic

Trial Locations (1)

171516

South Egypt Cancer instIitute, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT04613830 - Continuous Erector Spinae Block for Post Analgesia in Pediatric Patients | Biotech Hunter | Biotech Hunter